Dr. Daniel Leung, MD

NPI: 1861699654
Total Payments
$32,372
2024 Payments
$9,200
Companies
7
Transactions
30

Payment Breakdown by Category

Consulting$25,600 (79.1%)
Other$4,973 (15.4%)
Travel$1,152 (3.6%)
Food & Beverage$646.32 (2.0%)

Payments by Nature

Nature of Payment Amount Transactions Share
Consulting Fee $25,600 9 79.1%
Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program $4,973 1 15.4%
Travel and Lodging $1,152 7 3.6%
Food and Beverage $646.32 13 2.0%

Top Paying Companies

Company Total Records Latest Year
Mallinckrodt Hospital Products Inc. $9,200 1 $0 (2024)
Gilead Sciences, Inc. $8,856 20 $0 (2023)
Merck Sharp & Dohme Corporation $5,625 4 $0 (2020)
Vertex Pharmaceuticals Incorporated $4,973 1 $0 (2022)
AstraZeneca UK Limited $3,575 2 $0 (2023)
Alexion Pharmaceuticals, Inc. $117.19 1 $0 (2017)
ALBIREO PHARMA, INC. $25.60 1 $0 (2022)

Payment History by Year

Year Amount Transactions Top Company
2024 $9,200 1 Mallinckrodt Hospital Products Inc. ($9,200)
2023 $6,285 3 AstraZeneca UK Limited ($3,575)
2022 $4,999 2 Vertex Pharmaceuticals Incorporated ($4,973)
2020 $1,750 1 Merck Sharp & Dohme Corporation ($1,750)
2019 $8,317 19 Gilead Sciences, Inc. ($5,942)
2018 $1,575 2 Merck Sharp & Dohme Corporation ($1,500)
2017 $245.52 2 Gilead Sciences Inc ($128.33)

All Payment Transactions

30 individual payment records from CMS Open Payments — Page 1 of 2

Date Company Product Nature Form Amount Type
11/20/2024 Mallinckrodt Hospital Products Inc. TERLIVAZ (Drug) Consulting Fee Cash or cash equivalent $9,200.00 General
Category: CRITICAL CARE
12/19/2023 Gilead Sciences, Inc. Vemlidy (Drug) Consulting Fee Cash or cash equivalent $2,710.00 General
Category: HBV
09/22/2023 AstraZeneca UK Limited Consulting Fee Cash or cash equivalent $621.50 General
09/12/2023 AstraZeneca UK Limited Consulting Fee Cash or cash equivalent $2,953.50 General
09/22/2022 ALBIREO PHARMA, INC. Bylvay (Drug) Food and Beverage In-kind items and services $25.60 General
Category: Gastroenterology
01/13/2022 Vertex Pharmaceuticals Incorporated Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Cash or cash equivalent $4,973.00 General
07/15/2020 Merck Sharp & Dohme Corporation MK-5172 (Drug) Consulting Fee Cash or cash equivalent $1,750.00 General
Category: INFECTIOUS DISEASE
11/21/2019 Gilead Sciences, Inc. Food and Beverage In-kind items and services $72.00 General
11/21/2019 Gilead Sciences, Inc. Travel and Lodging In-kind items and services $35.59 General
11/21/2019 Gilead Sciences, Inc. Travel and Lodging In-kind items and services $29.00 General
11/21/2019 Gilead Sciences, Inc. Food and Beverage In-kind items and services $18.88 General
11/21/2019 Gilead Sciences, Inc. Food and Beverage In-kind items and services $15.12 General
11/21/2019 Gilead Sciences, Inc. Travel and Lodging In-kind items and services $14.00 General
11/21/2019 Gilead Sciences, Inc. Food and Beverage In-kind items and services $11.63 General
11/21/2019 Gilead Sciences, Inc. Travel and Lodging In-kind items and services $10.50 General
11/21/2019 Gilead Sciences, Inc. Food and Beverage In-kind items and services $7.57 General
11/21/2019 Gilead Sciences, Inc. Travel and Lodging In-kind items and services $3.00 General
10/24/2019 Gilead Sciences, Inc. Consulting Fee Cash or cash equivalent $4,490.00 General
10/15/2019 Gilead Sciences, Inc. Travel and Lodging In-kind items and services $643.36 General
10/15/2019 Gilead Sciences, Inc. Travel and Lodging In-kind items and services $416.78 General
10/15/2019 Gilead Sciences, Inc. Food and Beverage In-kind items and services $50.00 General
10/15/2019 Gilead Sciences, Inc. Food and Beverage In-kind items and services $50.00 General
10/15/2019 Gilead Sciences, Inc. Food and Beverage In-kind items and services $50.00 General
10/15/2019 Gilead Sciences, Inc. Food and Beverage In-kind items and services $25.00 General
08/14/2019 Merck Sharp & Dohme Corporation MK-5172 (Drug) Consulting Fee Cash or cash equivalent $1,250.00 General
Category: INFECTIOUS DISEASE

About Dr. Daniel Leung, MD

Dr. Daniel Leung, MD is a Pediatrics healthcare provider based in Houston, Texas. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/27/2007. The National Provider Identifier (NPI) number assigned to this provider is 1861699654.

According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Daniel Leung, MD has received a total of $32,372 in payments from pharmaceutical and medical device companies, with $9,200 received in 2024. These payments were reported across 30 transactions from 7 companies. The most common payment nature is "Consulting Fee" ($25,600).

Practice Information

  • Specialty Pediatrics
  • Other Specialties Pediatric Gastroenterology
  • Location Houston, TX
  • Active Since 06/27/2007
  • Last Updated 04/12/2024
  • Taxonomy Code 208000000X
  • Entity Type Individual
  • NPI Number 1861699654

Products in Payments

  • TERLIVAZ (Drug) $9,200
  • MK-5172 (Drug) $5,625
  • Vemlidy (Drug) $2,710
  • Kanuma (Drug) $117.19
  • Bylvay (Drug) $25.60

Data Sources

Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.

Pediatrics Doctors in Houston